INVE vs RTX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Identiv, Inc. (INVE) exhibits severe operational distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all financial health dimensions. While the company maintains an exceptionally strong liquidity position (Current Ratio of 15.19) and negligible debt, these are offset by a disastrous profit margin of -83.80% and declining year-over-year revenue growth of -7.90%. The stock trades below book value (P/B 0.62), but this appears to be a value trap given the lack of earnings and negative technical trend. Despite recent earnings beats, the company remains consistently unprofitable with a bearish long-term price trajectory.
RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.
Compare Another Pair
Related Comparisons
INVE vs RTX: Head-to-Head Comparison
This page compares Identiv, Inc. (INVE) and RTX Corporation (RTX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.